Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Zhengjiang Cheng"'
Autor:
Yulan Zheng, Shijun Jia, Lu Tang, Lu Yu, Xuejiao Yang, Shuai Yang, Qingtian Ke, Zhengjiang Cheng, Yufang Zhu, Hui Chen, Peng Hong
Publikováno v:
International Journal of Infectious Diseases, Vol 146, Iss , Pp 107164- (2024)
Objectives: SARS-CoV-2 infection could cause persistent lung injury or indicate potential genetic susceptibilities. Although infection-elicited hybrid immunity could protect against severe COVID-19, it remains unknown whether recent infection could r
Externí odkaz:
https://doaj.org/article/1967056f2e8c4f7ab56ab5cb1eb8e401
Publikováno v:
The Lancet. Microbe. 3(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d28cc0d3b5c2bcd67a5d7936de3cdff
https://pubmed.ncbi.nlm.nih.gov/35156067
https://pubmed.ncbi.nlm.nih.gov/35156067
Autor:
Yufang Zhu, Yingying Lu, Caili Zhou, Gangling Tong, Manman Gao, Yan Zhan, Yan Wang, Ran Liang, Yawei Li, Tianjiao Gao, Li Wang, Muyun Zhang, Jin Cheng, Jun Gong, Jimin Wang, Wei Zhang, Junhua Qi, Miao Cui, Longchao Zhu, Fenglian Xiao, Linyu Zhu, Yunsheng Xu, Zhihua Zheng, Zhiyu Zhou, Zhengjiang Cheng, Peng Hong
Publikováno v:
Med (New York, N.Y.). 3(8)
Emerging evidence suggests heterologous prime-boost COVID-19 vaccination as a superior strategy than homologous schedules. Animal experiments and clinical observations have shown enhanced antibody response against influenza variants after heterologou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4410261781e80725fa29ab63738ebbea
https://pubmed.ncbi.nlm.nih.gov/35679856
https://pubmed.ncbi.nlm.nih.gov/35679856
Autor:
Yufang Zhu, Yingying Lu, Lu Tang, Caili Zhou, Ran Liang, Miao Cui, Yunsheng Xu, Zhihua Zheng, Zhengjiang Cheng, Peng Hong
Publikováno v:
The Lancet Microbe. 3:e729
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73cf77b6ed6ac9a0336a1c5d422b741e
https://doi.org/10.1016/s2666-5247(22)00193-8
https://doi.org/10.1016/s2666-5247(22)00193-8
Autor:
Lingxiang Xing, Shaojun Huang, Zhengjiang Cheng, Hai-hui Ye, Xiu-ji Chen, Xiao-ying Han, Xiaolin Wang
Publikováno v:
Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban. 37(5)
HBV-associated acute-on-chronic liver failure is prevalent in mainland China. The prognosis of HBV-ACLF is poor. The mortality of HBV-ACLF is approximately 80%. Therefore, a prognostic indicator was needed in order to allow us to intervene as soon as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9b042e650870c73f07a21970622076f
https://pubmed.ncbi.nlm.nih.gov/29058291
https://pubmed.ncbi.nlm.nih.gov/29058291
Publikováno v:
Immunotherapy. 5:557-559
In many countries, a leading contributor of high mortality rates is cancer. Combinatorial therapy, including surgery, radiotherapy and chemo‐ therapy, are necessary approaches for treating cancer. Chemotherapy is a commonly used adjuvant therapy in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d90e0e8c9b7db0cec70cafa02420da8
https://doi.org/10.2217/imt.13.38
https://doi.org/10.2217/imt.13.38
Publikováno v:
Immunotherapy (1750743X); Jul2013, Vol. 5 Issue 6, p557-559, 3p
Autor:
Zhenzhen LI; Clinical Laboratory Medicine Department, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang 441053, China., Lanting Z; Medical College, Hubei University of Arts and Science, Xiangyang 441053, China., Lihong Z; Medical College, Hubei University of Arts and Science, Xiangyang 441053, China., Juan X; Medical College, Hubei University of Arts and Science, Xiangyang 441053, China., Zhengjiang C; Clinical Laboratory Medicine Department, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang 441053, China.
Publikováno v:
Nan fang yi ke da xue xue bao = Journal of Southern Medical University [Nan Fang Yi Ke Da Xue Xue Bao] 2020 Oct 30; Vol. 40 (10), pp. 1373-1379.